The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019 No. 744

Amendment of regulation 15 (ethics committee opinion) U.K.

8.  In regulation 15(5)(e) M1 , after “summary of product characteristics” insert “ , or equivalent document, ”.

Commencement Information

I1 Reg. 8 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

Marginal Citations

M1 Paragraph (5) was amended by S.I. 2006/1928.